Search and volunteer to participate in these available studies at UB. Your participation in research doesn't just benefit you, it helps advance healthcare for our entire community.

Highlighted Searches
Search Clinical Trials
Filter on any fields below
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Showing 61 - 69 of 69 Clinical Trials
Description:
This study enrolls children with schizophrenia. The purpose of this study is to learn if the study medication (cariprazine) is safe and useful for adolescents ages 13-17. Read More
Eligibility:
-Children ages 13-17.
-Diagnosed with schizophrenia.
Contact(s)
SEVIE KANDEFER
sk293@buffalo.edu
+1 716-898-4038
Description:
This study enrolls infants who are about 2 months old. The purpose of this study is to see if the MenACYW vaccine prevents meningococcal meningitis when given alongside the routine pediatric vaccines. Read More
Eligibility:
Children (infants) ages 42 to 89 days old.
Born at full term of pregnancy.
Have received the first dose of hepatitis B vaccine at least 28 days before the enrollment.
Contact(s)
Haiping Qiao
hqiao@buffalo.edu
+1 716-323-0055
Description:
This study enrolls adults and children with Primary Immunodeficiency Disease (PID). The purpose of the study is to learn about the effectiveness and safety of a medication that may treat this condition. It is called Kedrion intravenous immunoglobulin (IVIg) 10%. Read More
Eligibility:
-Adults and children ages 2-70.
-Diagnosed with PID and requiring treatment with IVIg.
-Documented agammaglobulinemia or hypogammaglobulinemia.
Contact(s)
Helena Mcclenahan
hmcclenahan@upa.chob.edu
+1 716-323-0062
Description:
This study enrolls children with myopia, or nearsightedness. The purpose of this study is to learn whether the use of SYD-101, an eye solution, slows down the progression of myopia in children. Read More
Eligibility:
-Children ages 3-14.
-Child must be in general good health.
-Must be diagnosed with myopia (nearsightedness) in both eyes.
Contact(s)
SHARON MICHALOVIC
sab1@buffalo.edu
+1 716-881-7975
Description:
This study enrolls children with type 1 diabetes. The study medication is called tepluzimab and has been administered to over 450 children with new onset T1D in prior trials and has shown promising improvement of beta cell function. The purpose of this study is to find out a definitive answer regarding the ability of teplizumab to help children with newly diagnosed type 1 diabetes in preserving their own insulin production. Read More
Eligibility:
Children ages 8-17 years (up to when a child turns 18) old who have been diagnosed with Type 1 diabetes in the last 6 weeks.
Contact(s)
AMANDA (AYLER) HOUSE
ajayler@buffalo.edu
+1 716-323-0075
Description:
This study enrolls children and youths ages 10-18 who are planning an elective surgery for treatment of Crohn’s or Ulcerative Colitis. The purpose of this study is to see how everything goes before, during, and after your surgery. Read More
Eligibility:
Youths ages 10-18
Diagnosis of Crohn's or Ulcerative Colitis and undergoing elective surgery treatment
Description:
This study enrolls children with Cystic Fibrosis (CF). The purpose of this study is to learn if a web and mobile device application, called MyMedSchedule Plus® (MMS+), helps people manage their CF treatments. Read More
Eligibility:
Ages 12+.
Diagnosed with Cystic Fibrosis (CF).
Are a patient at UBMD- CF Center of Western New York.
Contact(s)
SHARON MICHALOVIC
sab1@buffalo.edu
+1 716-881-7975
Description:
This study enrolls people who have participated in the preceding study, TrialNet Pathway to Prevention Study. The purpose of this study is to find out whether treatment of participants at Stage 1 Type 1 Diabetes with hydroxychloroquine delays progression to Stage 2 and Stage 3 Type 1 Diabetes. Please contact us to learn more about this research study. Read More
Eligibility:
Children ages 3+ and adults.
Must have participated in preceding study (potential study participants will be identified through the ongoing TrialNet Pathway to Prevention Study).
Contact(s)
AMANDA (AYLER) HOUSE
ajayler@buffalo.edu
+1 716-323-0075
Description:
This study enrolls newborns and their families. The purpose of this study is to learn more about newborn screening for immunodeficiency. Read More
Eligibility:
Newborns and their families in New York State.
Showing 61 - 69 of 69 Clinical Trials
Not finding what you are looking for? Add your profile to the Buffalo Research Registry or ResearchMatch to be matched with future studies.